Skip to main content
SpringerLink
Log in

Lamifiban

A Viewpoint by David J. Moliterno

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. Steiner B, Hofer U, Wittke B, et al. Plasma concentration of lamifiban and glycoprotein IIb-IIIa receptor occupancy best predict clinical outcome in patients with unstable angina: results from PARAGON A. Eur Heart J 1998; 19: 598

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

    David J. Moliterno

Authors
  1. David J. Moliterno
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moliterno, D.J. Lamifiban. Drugs 57, 222 (1999). https://doi.org/10.2165/00003495-199957020-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199957020-00011

Keywords

Search

Navigation